Pajjiż: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
glimepiride, Quantity: 2 mg
Arrotex Pharmaceuticals Pty Ltd
Glimepiride
Tablet, uncoated
Excipient Ingredients: microcrystalline cellulose; povidone; indigo carmine; magnesium stearate; sodium starch glycollate; iron oxide yellow; lactose monohydrate
Oral
30 tablets
(S4) Prescription Only Medicine
As an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with non-insulin dependent (type 2) diabetes mellitus.
Visual Identification: Green, capsule shaped tablet, embossed with "G2" scoreline "G2" one one side and scoreline on the other side.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2005-07-22
DIPRIDE- Consumer Medicine Information Page 1 of 5 Diapride glimepiride CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about DIAPRIDE. It does not contain all of the available information. It does not take the place of talking to your doctor, pharmacist or diabetes educator. All medicines have benefits and risks. Your doctor has weighed the risks of you taking DIAPRIDE against the benefits they expect it will have for you. TALK TO YOUR DOCTOR, PHARMACIST OR DIABETES EDUCATOR IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE. Keep this leaflet with your medicine. You may need to read it again. WHAT DIAPRIDE IS USED FOR DIAPRIDE is used to control blood glucose in patients with diabetes mellitus. There are two types of diabetes mellitus: • type 1, also called insulin dependent diabetes • type 2, also called non-insulin dependent diabetes mellitus or maturity onset diabetes. DIAPRIDE is used in the treatment of type 2 diabetes mellitus. It is used when diet and exercise are not enough to control your blood glucose levels. It is available only with a doctor's prescription. How DIAPRIDE works DIAPRIDE belongs to a group of medicines called sulphonylureas. The medicine lowers blood glucose by increasing the amount of insulin produced by your pancreas. If your blood glucose is not properly controlled, you may experience hypoglycaemia (low blood glucose) or hyperglycaemia (high blood glucose). Hypoglycaemia (low blood glucose) can occur suddenly. Signs may include: • weakness, trembling or shaking • sweating • lightheadedness, dizziness, headache, lack of concentration • irritability, tearfulness, crying • hunger • numbness around the lips and tongue. If not treated promptly, these may progress to: • loss of co-ordination • slurred speech • confusion • fits or loss of consciousness. Hyperglycaemia (high blood glucose) usually occurs more slowly than hypoglycaemia. Signs may include: • lethargy or tiredness • headache • thirst • pass Aqra d-dokument sħiħ
DIAPRIDE- Product Information Page 1 of 14 AUSTRALIAN PRODUCT INFORMATION – DIAPRIDE (GLIMEPIRIDE) TABLETS 1 NAME OF THE MEDICINE Glimepiride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Diapride tablets come in four strengths and contain either 1 mg, 2 mg, 3 mg or 4 mg of glimepiride. Excipients of known effect: lactose monohydrate. For the full list of excipients, see Section 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM DIAPRIDE 1 1 mg: Pink, round tablet, G1 on one side and plain on the other. DIAPRIDE 2 2 mg: Green, capsule-shaped tablet, G2, scoreline, G2 on one side and scoreline on the other. DIAPRIDE 3 3 mg: Pale yellow, capsule-shaped tablet, G3, scoreline, G3 on one side and scoreline on the other. DIAPRIDE 4 4 mg: Blue, capsule-shaped tablet, G4, scoreline, G4 on one side and scoreline on the other. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS As an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with noninsulin dependent type 2 diabetes mellitus. 4.2 D OSE AND METHOD OF ADMINISTRATION In the management of type 2 diabetes mellitus, administration of an oral antidiabetic agent is not a substitute for appropriate dietary control. In initiating treatment for type 2 diabetes mellitus, diet should be emphasised as the primary form of treatment. Caloric restriction and weight loss are essential in the obese diabetic patient. Proper DIAPRIDE- Product Information Page 2 of 14 dietary management alone may be effective in controlling the blood glucose and symptoms of hyperglycaemia. The importance of regular physical activity should also be stressed, and cardiovascular risk factors should be identified and corrective measures taken where possible. If this treatment program fails to reduce symptoms and/or blood glucose, the use of an oral sulfonylurea should be considered. Use of glimepiride must be viewed by both the physician and patient as a treatment in addition to diet, and not as a substitute for diet or as a convenient mechanism for avoiding dietary restraint. Furt Aqra d-dokument sħiħ